|
Cohance Lifesciences Ltd.
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
|
|
BSE Code |
543064
|
|
ISIN Demat |
INE03QK01018
|
|
Book Value (Rs) |
62.24
|
|
|
NSE Code |
COHANCE
|
|
Dividend Yield (%) |
0.00
|
|
Market Cap (Rs Mn) |
342340.21
|
|
|
TTM PE(x) |
131.88
|
|
TTM EPS(Rs) |
6.79
|
|
Face Value(Rs.) |
1
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
06-11 2018
|
|
Registered Office
|
215 Atrium, C Wing, 8th Floor, 819-821,Andheri, Kurla Road, Chakala,Andheri (East), Chakala Midc, Mumbai,
Maharashtra-400093 .
|
|
ISINNO
|
INE03QK01018
|
|
Phone
|
022-61539999
|
|
E-mail
|
info@suvenpharm.com |
|
URL
|
www.suvenpharm.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Vivek Sharma
|
|
Managing Director
|
V Prasada Raju
|
|
Company Secretary
|
Kundan Kumar Jha
|
|
Listing
|
BSE,NSE
|
|
|